Method of Treating Lung Adenocarcinoma

摘要

This invention is directed to the treatment of cancer in a patient, particularly a patient with lung adenocarcinoma, and more particularly a patient with SLC34A2-ROS1, CD74-ROS1, or FIG-ROS1 fusion-positive non-small cell lung cancer, with an inhibitor of MET, VEGFR2, and ROS1 which is a compound of Formula (I): or a pharmaceutically acceptable salt thereof.;

主权项

1. A method for treating lung adenocarcinoma, comprising administering to a patient in need of such treatment a compound of Formula I: or a pharmaceutically acceptable salt thereof, wherein:
R1 is halo;R2 is halo;R3 is (C1-C6)alkyl;R4 is (C1-C6)alkyl; andQ is CH or N.